C-Reactive Protein Testing Market Size To Reach USD 1.93 Billion By 2028 Says Reports And Data
The latest report on the Global
C-Reactive Protein Testing Market published by Reports and Data
presents a comprehensive analysis of the industry size, revenue forecast,
regional spectrum of the business vertical, and further elaborates on the
limitations, challenges, opportunities and growth prospects. It offers a
comprehensive industry overview along with in-depth assessment of top companies
and recent developments in the market. It also provides information on the
growth strategies adopted by the prominent industry players and a comprehensive
overview of the competitive landscape of the market.
Furthermore, the report covers
various important aspects of the industry such current and emerging trends,
updated outlines, growth factors, restraints, growth prospects and
opportunities, regulatory framework and government policies, macro and micro
economic factors, and other factors that enable to draw projections for the
estimated market growth in the forecast period.
C-Reactive Protein Testing Market Size – USD 1.67 Billion in 2020, Growth –
at a CAGR of 1.8%, Trends – Rapid adoption of point-of-care CRP testing
Key companies
operating in the global market and profiled in the report include:
Thermo Fisher
Scientific, Inc., F. Hoffmann-La Roche Ltd., Danaher, Quest Diagnostics
Incorporated, Siemens, Abbott Laboratories, Laboratory Corporation of America
Holdings, Merck KGaA, Abaxis, Inc., Ortho Clinical Diagnostics, Getein Biotech,
Inc., HORIBA, Ltd., Randox Laboratories Ltd., Aidianm, and BODITECH MED INC
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4051
Get to know the business better:
The global C-Reactive Protein Testing market research is
carried out at the different stages of the business lifecycle from the
production of a product, cost, launch, application, consumption volume and
sale. The research offers valuable insights into the marketplace from the
beginning including some sound business plans chalked out by prominent market
leaders to establish a strong foothold and expand their products into one
that’s better than others.
For the purpose of this report, Reports and Data has segmented the
C-reactive protein testing market based on assay type, application, end-use,
and region:
Assay Type
Outlook (Revenue, USD Billion; 2018-2028)
- ELISA
- Turbidometric
- Immunoturbidometric
Application
Outlook (Revenue, USD Billion; 2018-2028)
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
Ask for discount @ https://www.reportsanddata.com/request-customization-form/4051
End-use Outlook
(Revenue, USD Billion; 2018-2028)
- Clinics
- Hospitals
- Diagnostic Labs
Regional analysis covers:
·
North
America (U.S., Canada, Mexico)
·
Europe
(U.K., Italy, Germany, France, Rest of Europe)
·
Asia
Pacific (India, Japan, China, South Korea, Australia,
Rest of APAC)
·
Latin
America (Chile, Brazil, Argentina, Rest of Latin
America)
·
Middle
East & Africa (Saudi Arabia, U.A.E., South Africa,
Rest of MEA)
Some Key
Highlights From the Report:
·
Immunoturbidimetric assay segment is expected to
account for largest revenue share during the forecast period attributable to
rapid development and availability of cost-effective automated and sensitive
assays.
·
Cardiovascular disease segment is expected to
register robust revenue growth over the forecast period owing to increasing
global prevalence of cardiovascular conditions, growing demand for quick
diagnostic methods, rising need for early detection, and large number of
C-reactive protein tests performed for diagnosis of CVD.
·
Clinics segment is expected to register considerable
revenue growth between 2021 and 2028 owing to increasing adoption of POC CRP
testing in primary care settings, cost-effectiveness, and need for rapid and
accurate results.
·
North America is expected to account for largest
revenue share over the forecast period attributable to increasing incidence of
CVD, rheumatoid arthritis, and other inflammatory conditions, presence of
well-established healthcare infrastructure, and favorable reimbursement
scenario.
Key
Reasons for Purchasing Global C-Reactive Protein Testing Market Report:
• New approaches and latest development trend that
describe the structure of the market
• Advanced market breakdown structure
• Historical data and future market scope
• In-depth market analysis based on statistics, growth
stimulators, and market developments
• Statistical data representation through figurative,
numerical, and theoretical elaboration
• Report provides insight of the business and sales
activities
• Key competitive players and regional distribution will help
find prospective market analytics
• Report will strengthen the investors’ decision-making
processes
Speak to Analyst @ https://www.reportsanddata.com/speak-to-analyst-form/4051
Thank you for reading our report. To
know more about the customization of the report or further query about the
report, please get in touch with us. Our team will ensure the report is well
suited to your requirements.
Read More:
Comments
Post a Comment